Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jose Perez, Laia Garrigós, Maria Gion, Pasi A. Jänne, Kohei Shitara, Salvatore Siena & Javier Cortés. (2021) Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond. Expert Opinion on Biological Therapy 21:7, pages 811-824.
Read now
Read now
Az-Eddine El Mansouri, Mohamed Maatallah, Hassan Ait Benhassou, Abdeladim Moumen, Ahmad Mehdi, Robert Snoeck, Graciela Andrei, Mohamed Zahouily & Hassan B. Lazrek. (2020) Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs. Nucleosides, Nucleotides & Nucleic Acids 39:8, pages 1088-1107.
Read now
Read now
Chien-Chun Li, Hsien-Tsung Yao, Fang-Ju Cheng, Yi-Hsien Hsieh, Chia-Yang Lu, Chih-Chung Wu, Kai-Li Liu & Jer-Wei Chang. (2015) Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells. Nutrition and Cancer 67:5, pages 771-782.
Read now
Read now
N Porther & MA Barbieri. (2015) The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells. Small GTPases 6:3, pages 135-144.
Read now
Read now
Sarah Rofaiel, Esther N Muo & Shaker A Mousa. (2010) Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management. Pharmacogenomics and Personalized Medicine 3, pages 129-143.
Read now
Read now
Fernanda Milanezi, Dina Leitão, Sara Ricardo, Isabel Augusto & Fernando Schmitt. (2009) Evaluation of HER2 in breast cancer: reality and expectations. Expert Opinion on Medical Diagnostics 3:6, pages 607-620.
Read now
Read now
Ferdinando Mannello, Virginia Medda & Gaetana A Tonti. (2009) Protein profile ana lysis of the breast microenvironment to differentiate healthy women from breast cancer patients. Expert Review of Proteomics 6:1, pages 43-60.
Read now
Read now
Articles from other publishers (65)
Ritchu Babbar, Vanya, Aarti Bassi, Rashmi Arora, Ankur Aggarwal, Pranay Wal, Sunil Kumar Dwivedi, Salma Alolayan, Monica Gulati, Celia Vargas-De-La-Cruz, Tapan Behl & Shreesh Ojha. (2023) Understanding the promising role of antibody drug conjugates in breast and ovarian cancer. Heliyon 9:11, pages e21425.
Crossref
Crossref
Se Been Kim, Chae-Eun Yang, Yurim Jeong, Minseo Yu, Wan-Su Choi, Jung-Yeon Lim & Youngwoo Jeon. (2023) Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma. Cancers 15:18, pages 4472.
Crossref
Crossref
Qing Ye, Jiajia Wang, Barbara Ducatman, Rebecca A. Raese, Jillian L. Rogers, Ying-Wooi Wan, Chunlin Dong, Lindsay Padden, Elena N. Pugacheva, Yong Qian & Nancy Lan Guo. (2023) Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. International Journal of Molecular Sciences 24:13, pages 10561.
Crossref
Crossref
Shayalini Wignarajah, Iva Chianella & Ibtisam E. Tothill. (2023) Development of Electrochemical Immunosensors for HER-1 and HER-2 Analysis in Serum for Breast Cancer Patients. Biosensors 13:3, pages 355.
Crossref
Crossref
Roger Riera, Emmanouil Archontakis, Glenn Cremers, Tom de Greef, Peter Zijlstra & Lorenzo Albertazzi. (2023) Precision and Accuracy of Receptor Quantification on Synthetic and Biological Surfaces Using DNA-PAINT. ACS Sensors 8:1, pages 80-93.
Crossref
Crossref
Xiaolu Sun, Kuai Liu, Shuli Lu, Weina He & Zixiu Du. (2022) Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer. Cancers 14:21, pages 5456.
Crossref
Crossref
Jinhua Wang, Dangdang Li, Bo Zhao, Juhyok Kim, Guangchao Sui & Jinming Shi. (2022) Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression. International Journal of Molecular Sciences 23:5, pages 2672.
Crossref
Crossref
Abdolamir Ghadaksaz, Abbas Ali Imani Fooladi, Hamideh Mahmoodzadeh Hosseini, Taher Nejad Satari & Mohsen Amin. (2021) ARA-linker-TGFαL3: a novel chimera protein to target breast cancer cells. Medical Oncology 38:8.
Crossref
Crossref
Christine Goudsmit, Felipe da Veiga Leprevost, Venkatesha Basrur, Lila Peters, Alexey Nesvizhskii & Heather Walline. (2021) Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status. Cancers 13:15, pages 3714.
Crossref
Crossref
Samantha C. Sodergren, Sally J. Wheelwright, Deborah Fitzsimmons, Fabio Efficace, Mirjam Sprangers, Peter Fayers, Amelie Harle, Heike Schmidt, Andrew Bottomley, Anne-Sophie Darlington, Charlotte Benson, Anne Bredart, Leopold Hentschel, Juan Ignacio Arraras, Georgios Ioannidis, Michael Leahy, Iwona Lugowska, Ourania Nicolatou-Galitis, Duska Petranovic, Gudrun E Rohde, Vasilis Vassiliou & Colin D. Johnson. (2020) Developing Symptom Lists for People with Cancer Treated with Targeted Therapies. Targeted Oncology 16:1, pages 95-107.
Crossref
Crossref
CJY Liew, LCH Leong, LLS Teo, CC Ong, FK Cheah, WP Tham, HMM Salahudeen, CH Lee, GJL Kaw, AKH Tee, IYY Tsou, KH Tay, R Quah, BP Tan, H Chou, D Tan, ACC Poh & AGS Tan. (2019) A practical and adaptive approach to lung cancer screening: a review of international evidence and position on CT lung cancer screening in the Singaporean population by the College of Radiologists Singapore. Singapore Medical Journal 60:11, pages 554-559.
Crossref
Crossref
Rodrigo de Andrade Natal, Geisilene R. Paiva, Vitor B. Pelegati, Ludwing Marenco, César A. Alvarenga, Renato F. Vargas, Sophie F. Derchain, Luis O. Sarian, Camille Franchet, Carlos L. Cesar, Fernando C. Schmitt, Britta Weigelt & José Vassallo. (2019) Exploring Collagen Parameters in Pure Special Types of Invasive Breast Cancer. Scientific Reports 9:1.
Crossref
Crossref
Dana Silverbush, Simona Cristea, Gali Yanovich-Arad, Tamar Geiger, Niko Beerenwinkel & Roded Sharan. (2019) Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules. Cell Systems 8:5, pages 456-466.e5.
Crossref
Crossref
Tomasz Jodlowski & K. H. Ramesh. 2019. Molecular Diagnostics in Cancer Patients. Molecular Diagnostics in Cancer Patients
237
268
.
Deeptashree Nandi, Pradeep Singh Cheema, Neha Jaiswal & Alo Nag. (2018) FoxM1: Repurposing an oncogene as a biomarker. Seminars in Cancer Biology 52, pages 74-84.
Crossref
Crossref
Wanil Kim, Kyung-Yoon Na, Kyung-Ha Lee, Hyun Wook Lee, Jae Koo Lee & Kyong-Tai Kim. (2017) Selective uptake of epidermal growth factor-conjugated gold nanoparticle (EGF-GNP) facilitates non-thermal plasma (NTP)-mediated cell death. Scientific Reports 7:1.
Crossref
Crossref
Renan B. Ferreira, Mengxiong Wang, Mary E. Law, Bradley J. Davis, Ashton N. Bartley, Paul J. Higgins, Michael S. Kilberg, Katherine E. Santostefano, Naohiro Terada, Coy D. Heldermon, Ronald K. Castellano & Brian K. Law. (2017) Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells. Oncotarget 8:17, pages 28971-28989.
Crossref
Crossref
Tatiana A. Kolesnikova, Gayane Kiragosyan, Trang H. N. Le, Sebastian Springer & Mathias Winterhalter. (2017) Protein A Functionalized Polyelectrolyte Microcapsules as a Universal Platform for Enhanced Targeting of Cell Surface Receptors. ACS Applied Materials & Interfaces 9:13, pages 11506-11517.
Crossref
Crossref
Xue Qiu, K. David Wegner, Yu-Tang Wu, Paul M. P. van Bergen en Henegouwen, Travis L. Jennings & Niko Hildebrandt. (2016) Nanobodies and Antibodies for Duplexed EGFR/HER2 Immunoassays Using Terbium-to-Quantum Dot FRET. Chemistry of Materials 28:22, pages 8256-8267.
Crossref
Crossref
Andreia Granja, Marina Pinheiro & Salette Reis. (2016) Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy. Nutrients 8:5, pages 307.
Crossref
Crossref
Lan Wang, Jueheng Wu, Jie Yuan, Xun Zhu, Hongmei Wu & Mengfeng Li. (2016) Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo. Frontiers of Medicine 10:1, pages 41-51.
Crossref
Crossref
Sicong Hou, Tomoya Isaji, Qinglei Hang, Sanghun Im, Tomohiko Fukuda & Jianguo Gu. (2016) Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells. Scientific Reports 6:1.
Crossref
Crossref
Byumseok Koh, Xiaoyang Li, Bo Zhang, Bing Yuan, Yi Lin, Alexander L. Antaris, Hao Wan, Ming Gong, Jiang Yang, Xiaodong Zhang, Yongye Liang & Hongjie Dai. (2016) Visible to Near-Infrared Fluorescence Enhanced Cellular Imaging on Plasmonic Gold Chips. Small 12:4, pages 457-465.
Crossref
Crossref
William Jacot, Caroline Mollevi, Frédéric Fina, Evelyne Lopez-Crapez, Pierre-Marie Martin, Pierre-Emmanuel Colombo, Frédéric Bibeau, Gilles Romieu & Pierre-Jean Lamy. (2015) High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers. BMC Cancer 15:1.
Crossref
Crossref
Ana I. Faustino-Rocha, Rita Ferreira, Paula A. Oliveira, Adelina Gama & Mário Ginja. (2015) N-Methyl-N-nitrosourea as a mammary carcinogenic agent. Tumor Biology 36:12, pages 9095-9117.
Crossref
Crossref
Inmaculada de Juan, Sarai Palanca, Asunción Domenech, Lidia Feliubadaló, Ángel Segura, Ana Osorio, Isabel Chirivella, Miguel de la Hoya, Ana Beatriz Sánchez, Mar Infante, Isabel Tena, Orland Díez, Zaida Garcia-Casado, Ana Vega, Àlex Teulé, Alicia Barroso, Pedro Pérez, Mercedes Durán, Estela Carrasco, Mª José Juan-Fita, Rosa Murria, Marta Llop, Eva Barragan, Ángel Izquierdo, Javier Benítez, Trinidad Caldés, Dolores Salas & Pascual Bolufer. (2015) BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study. Familial Cancer 14:4, pages 505-513.
Crossref
Crossref
Victoria Shang Wu, Noriko Kanaya, Chiao Lo, Joanne Mortimer & Shiuan Chen. (2015) From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?. The Journal of Steroid Biochemistry and Molecular Biology 153, pages 45-53.
Crossref
Crossref
Ying Huang, Zakaria Rachid, Lisa Peyrard, Zhor Senhaji Mouhri, Christopher Williams & Bertrand J. Jean-Claude. (2015) Positional Isomerization of A Non-Cleavable Combi-Molecule Dramatically Altered Tumor Cell Response Profile. Chemical Biology & Drug Design 85:2, pages 153-162.
Crossref
Crossref
James A. McCubrey, Stephen L. Abrams, Timothy L. Fitzgerald, Lucio Cocco, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello, Aurora Scalisi, Saverio Candido, Massimo Libra & Linda S. Steelman. (2015) Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis. Advances in Biological Regulation 57, pages 75-101.
Crossref
Crossref
Armel Herve Nwabo Kamdje, Paul Faustin Seke Etet, Lorella Vecchio, Jean Marc Muller, Mauro Krampera & Kiven Erique Lukong. (2014) Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment. Cellular Signalling 26:12, pages 2843-2856.
Crossref
Crossref
Nicole M. Davis, Melissa Sokolosky, Kristin Stadelman, Stephen L. Abrams, Massimo Libra, Saverio Candido, Ferdinando Nicoletti, Jerry Polesel, Roberta Maestro, Antonino D’Assoro, Lyudmyla Drobot, Dariusz Rakus, Agnieszka Gizak, Piotr Laidler, Joanna Dulińska-Litewka, Joerg Basecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Giuseppe Montalto, Melchiorre Cervello, Timothy L. Fitzgerald, Zoya N. Demidenko, Alberto M. Martelli, Lucio Cocco, Linda S. Steelman & James A. McCubrey. (2014) Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget 5:13, pages 4603-4650.
Crossref
Crossref
Clinton F. Stewart, Michael Tagen, Lee S. Schwartzberg, L. Johnetta Blakely, Kurt W. Tauer & Linda M. Smiley. (2014) Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors. Cancer Chemotherapy and Pharmacology 73:3, pages 561-568.
Crossref
Crossref
Jingjuan Qiao, Shenghui Xue, Fan Pu, Natalie White, Jie Jiang, Zhi-Ren Liu & Jenny J. Yang. (2013) Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents. JBIC Journal of Biological Inorganic Chemistry 19:2, pages 259-270.
Crossref
Crossref
Rosa Murria Estal, Sarai Palanca Suela, Inmaculada de Juan Jiménez, Cecilia Egoavil Rojas, Zaida García-Casado, María José Juan Fita, Ana Beatriz Sánchez Heras, Ángel Segura Huerta, Isabel Chirivella González, Dolors Sánchez-Izquierdo, Marta Llop García, Eva Barragán González & Pascual Bolufer Gilabert. (2013) MicroRNA signatures in hereditary breast cancer. Breast Cancer Research and Treatment 142:1, pages 19-30.
Crossref
Crossref
Ying-Bo Li, Zhong-Qing Wang, Xu Yan, Mei-Wan Chen, Jiao-Lin Bao, Guo-Sheng Wu, Ze-Mei Ge, De-Min Zhou, Yi-Tao Wang & Run-Tao Li. (2013) IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities. Cancer Letters 340:1, pages 88-96.
Crossref
Crossref
Xiaoni Li, Xin Liu, Weiyi Xu, Peng Zhou, Ping Gao, Songshan Jiang, Peter E. Lobie & Tao Zhu. (2013) c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2. Journal of Biological Chemistry 288:25, pages 18121-18133.
Crossref
Crossref
Won HwangboJeong Hyeon LeeSangjeong AhnSeojin KimKyong Hwa ParkChul Hwan KimInsun Kim. (2013)
EGFR
Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast
. Korean Journal of Pathology 47:2, pages 107.
Crossref
Crossref
Zhenzhen Hu, Xiuqin Jiang, Ying Xu, Nan Lu, Weizhi Wang, Jie Luo, Han Zou, Datong Zheng & Xing Feng. (2012) Downregulation of galectin-3 by EGF mediates the apoptosis of HepG2 cells. Molecular and Cellular Biochemistry 369:1-2, pages 157-165.
Crossref
Crossref
Zachary M. Carrico, Michelle E. Farkas, Yu Zhou, Sonny C. Hsiao, James D. Marks, Harshal Chokhawala, Douglas S. Clark & Matthew B. Francis. (2012) N-Terminal Labeling of Filamentous Phage To Create Cancer Marker Imaging Agents. ACS Nano 6:8, pages 6675-6680.
Crossref
Crossref
Eylem Aydoğdu, Anne Katchy, Efrosini Tsouko, Chin-Yo Lin, Lars-Arne Haldosén, Luisa Helguero & Cecilia Williams. (2012) MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis 33:8, pages 1502-1511.
Crossref
Crossref
Jaclyn F. Hechtman & Alexandros D. Polydorides. (2012) HER2/neu Gene Amplification and Protein Overexpression in Gastric and Gastroesophageal Junction Adenocarcinoma: A Review of Histopathology, Diagnostic Testing, and Clinical Implications. Archives of Pathology & Laboratory Medicine 136:6, pages 691-697.
Crossref
Crossref
Anna Kakehashi, Yoshiyuki Tago, Midori Yoshida, Yui Sokuza, Min Wei, Shoji Fukushima & Hideki Wanibuchi. (2012) Hormonally Active Doses of Isoflavone Aglycones Promote Mammary and Endometrial Carcinogenesis and Alter the Molecular Tumor Environment in Donryu Rats. Toxicological Sciences 126:1, pages 39-51.
Crossref
Crossref
Pengxu Qian, Zehua Zuo, Zhengsheng Wu, Xianyi Meng, Gaopeng Li, Zhengzhou Wu, Weijie Zhang, Sheng Tan, Vijay Pandey, Yandan Yao, Puyue Wang, Liqing Zhao, Jun Wang, Qiang Wu, Erwei Song, Peter E. Lobie, Zhinan Yin & Tao Zhu. (2011)
Pivotal Role of Reduced
let-7g
Expression in Breast Cancer Invasion and Metastasis
. Cancer Research 71:20, pages 6463-6474.
Crossref
Crossref
Edgar S. Díaz-Cruz, Yasuro Sugimoto, G. Ian Gallicano, Robert W. Brueggemeier & Priscilla A. Furth. (2011) Comparison of Increased Aromatase versus ERα in the Generation of Mammary Hyperplasia and Cancer. Cancer Research 71:16, pages 5477-5487.
Crossref
Crossref
Mogens Bernsdorf, Christian Ingvar, Leif Jörgensen, Malgorzata K. Tuxen, Erik H. Jakobsen, Anna Saetersdal, Marie Louise Kimper-Karl, Niels Kroman, Eva Balslev & Bent Ejlertsen. (2011) Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial. Breast Cancer Research and Treatment 126:2, pages 463-470.
Crossref
Crossref
Wilson Mejía, Carlos Castro, Adriana Umaña, Clemencia De Castro, Tulia Riveros & Myriam Sánchez-Gómez. (2011) Señalización asociada al receptor del factor de crecimiento similar a la insulina de tipo I en una línea celular colombiana de carcinoma mamario. Biomédica 30:4, pages 551.
Crossref
Crossref
Ying Huang, Zakaria Rachid & Bertrand J. Jean-Claude. (2011) MGMT Is a Molecular Determinant for Potency of the DNA-EGFR–Combi-Molecule ZRS1. Molecular Cancer Research 9:3, pages 320-331.
Crossref
Crossref
Roshawn G. Watson & Howard L. McLeod. (2011) Pharmacogenomic Contribution to Drug Response. The Cancer Journal 17:2, pages 80-88.
Crossref
Crossref
Sebastian Schmeier, Ulf Schaefer, Cameron R. MacPherson & Vladimir B. Bajic. (2011) dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes. PLoS ONE 6:2, pages e16657.
Crossref
Crossref
James E. Boers, Harriëtte Meeuwissen & Natalie Methorst. (2011) HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH). Histopathology 58:3, pages 383-394.
Crossref
Crossref
Saevar Ingthorsson, Thorhallur Halldorsson, Valgardur Sigurdsson, Agla JR Friðriksdottir, Sigridur K. Bodvarsdottir, Margret Steinarsdottir, Oskar Johannsson, Magnus K. Magnusson, Helga M. Ogmundsdottir & Thorarinn Gudjonsson. (2010) Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background. In Vitro Cellular & Developmental Biology - Animal 47:2, pages 139-148.
Crossref
Crossref
Jinpu Yu, Jingyan Sun, Shizhen Emily Wang, Hui Li, Shui Cao, Yizi Cong, Juntian Liu & Xiubao Ren. (2011)
Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T Cells
In Situ
and Lymph Node Metastasis
. Clinical and Developmental Immunology 2011, pages 1-10.
Crossref
Crossref
Pawel Domagala, Tomasz Huzarski, Jan Lubinski, Karol Gugala & Wenancjusz Domagala. (2010) Immunophenotypic predictive profiling of BRCA1-associated breast cancer. Virchows Archiv 458:1, pages 55-64.
Crossref
Crossref
Alfonso Sánchez-Muñoz, Elena Gallego, Vanessa de Luque, Luís G Pérez-Rivas, Luís Vicioso, Nuria Ribelles, José Lozano & Emilio Alba. (2010) Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer. BMC Cancer 10:1.
Crossref
Crossref
Mark E. Sharafinski, Robert L. Ferris, Soldano Ferrone & Jennifer R. Grandis. (2010) Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head & Neck 32:10, pages 1412-1421.
Crossref
Crossref
Fernando C. Schmitt. (2010) Demystifying Molecular Cytopathology. International Journal of Surgical Pathology 18:3_suppl, pages 213-215.
Crossref
Crossref
Lee S. Rosen, Helen Louise Ashurst & Linnea Chap. (2010) Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review. The Oncologist 15:3, pages 216-235.
Crossref
Crossref
Ita Hadžisejdić, Elvira Mustać, Nives Jonjić, Marija Petković & Blaženka Grahovac. (2010) Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis. Modern Pathology 23:3, pages 392-403.
Crossref
Crossref
Monika L. Burness, Tatyana A. Grushko & Olufunmilayo I. Olopade. (2010) Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer. The Cancer Journal 16:1, pages 23-32.
Crossref
Crossref
Tanja Schneider-Merck & Martin Trepel. 2010. Small Molecules in Oncology. Small Molecules in Oncology
45
59
.
Xiaoying Ye, Donald J. JohannJr.Jr., Ramin M. Hakami, Zhen Xiao, Zhaojing Meng, Robert G. Ulrich, Haleem J. Issaq, Timothy D. Veenstra & Josip Blonder. (2009) Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS. Journal of Proteomics 73:1, pages 112-122.
Crossref
Crossref
Naeem Amiry, Xiangjun Kong, Nethaji Muniraj, Nagarajan Kannan, Prudence M. Grandison, Juan Lin, Yulu Yang, Cécile M. Vouyovitch, Sahra Borges, Jo K. Perry, Hichem C. Mertani, Tao Zhu, Dongxu Liu & Peter E. Lobie. (2009) Trefoil Factor-1 (TFF1) Enhances Oncogenicity of Mammary Carcinoma Cells. Endocrinology 150:10, pages 4473-4483.
Crossref
Crossref
Kiran K. Mantripragada, Teresita Díaz de Ståhl, Chris Patridge, Uwe Menzel, Robin Andersson, Nadia Chuzhanova, Lan Kluwe, Abhijit Guha, Victor Mautner, Jan P. Dumanski & Meena Upadhyaya. (2009) Genome‐wide high‐resolution analysis of DNA copy number alterations in NF1‐associated malignant peripheral nerve sheath tumors using 32K BAC array. Genes, Chromosomes and Cancer 48:10, pages 897-907.
Crossref
Crossref
Sevtap Savas, Joseph Geraci, Igor Jurisica & Geoffrey Liu. (2009) A comprehensive catalogue of functional genetic variations in the EGFR pathway: Protein-protein interaction analysis reveals novel genes and polymorphisms important for cancer research. International Journal of Cancer 125:6, pages 1257-1265.
Crossref
Crossref
Fernando Schmitt. (2009) HER2+ breast cancer: How to evaluate?. Advances in Therapy 26:S1, pages 1-8.
Crossref
Crossref